South Africa, China advance health cooperation amid regional Ebola outbreak

South Africa and China are exploring ways to translate their bilateral health cooperation agreement into practical collaboration, with medical research, infectious disease control, healthcare capacity building and specialized treatment among the priority areas discussed during a meeting between South African Health Minister Dr Aaron Motsoaledi and Chinese Ambassador to South Africa Wu Peng in Pretoria on Monday.

The meeting, held at the AB Xuma offices, focused on implementing the Memorandum of Understanding (MoU) on cooperation in the health sector and medical sciences, signed by Dr. Motsoaledi and Chinese Health Minister Lei Haichao in May 2026. The discussions also addressed collaboration in response to the Ebola outbreak, placing infectious disease preparedness within the broader framework of bilateral health cooperation.

The proposed implementation plan identifies seven priority areas: medical science research; science and technology; infectious diseases; capacity building and the exchange of experiences; traditional medicine and regulation; cancer treatment; and nuclear medicine.

A central issue in the discussions was collaboration on Ebola, as the outbreak in Central Africa has highlighted the importance of disease surveillance, timely diagnosis, effective clinical management and coordination across national borders.

Beyond infectious disease control, the MoU provides a basis for broader engagement in medical research and healthcare development. Medical science research and science and technology are identified as priority areas, creating scope for collaboration in scientific knowledge exchange and the exploration of approaches that can strengthen healthcare systems.

Capacity building and the sharing of experiences also feature prominently in the proposed implementation plan. Such cooperation can support the exchange of professional expertise and institutional knowledge, while providing opportunities for healthcare practitioners and researchers to learn from developments in each country's health system.

Traditional medicine and regulation constitute another area of potential engagement, alongside cancer treatment and nuclear medicine. These specialized fields present distinct opportunities for scientific exchange, regulatory dialogue and cooperation in medical practice and research. Their inclusion in the implementation plan signals an intention to address a broad range of healthcare needs rather than limiting bilateral engagement to emergency disease response.

For South Africa and China, the health partnership offers a framework for combining medical expertise, research capabilities and institutional experience in addressing shared public-health challenges. The discussions in Pretoria demonstrate continued engagement on the implementation of the May agreement, with infectious disease preparedness and broader medical cooperation forming part of the agenda.

As both countries work towards giving effect to the MoU, the focus will be on identifying concrete areas in which cooperation can strengthen research, develop professional capacity and support improved healthcare outcomes.